Background: This study aimed to investigate risk factors for colonisation with extensively drug-resistant P. aeruginosa (XDR-PA) in immunocompromised patients and to build a clinical risk score (CRS) based on these results.
Methods: We conducted a matched case-control study with 31 cases and 93 controls (1:3).